Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- PMID: 28792849
- DOI: 10.1056/NEJMx170012
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Erratum for
-
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4. N Engl J Med. 2017. PMID: 28578601 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources